查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲肌肉減少症治療市場預測至 2030 年 - 區域分析 - 按治療類型和配銷通路
市場調查報告書
商品編碼
1562394

歐洲肌肉減少症治療市場預測至 2030 年 - 區域分析 - 按治療類型和配銷通路

Europe Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 78 Pages | 訂單完成後即時交付

價格

2022年歐洲肌肉減少症治療市值為9.9346億美元，預計2030年將達到14.6781億美元；預計2022年至2030年複合年成長率為5.0%。

成人營養不良和維生素缺乏症的增加推動了歐洲肌少症治療市場的發展

營養不良是肌少症的主要危險因子之一。據世界衛生組織稱，截至 2021 年，全球約有 23 億成年人營養不良，佔全球人口的近 30%。在已報告的危險因子中，蛋白質能量缺乏是肌少症的常見原因。此外，維生素 D 缺乏或不足與多種疾病的風險增加呈正相關，例如癌症、肥胖、心血管疾病和肌少症。根據美國國立衛生研究院 (NIH) 的數據，全球近 50% 的人口缺乏維生素 D，約 10 億人缺乏維生素 D。

歐洲少肌症治療市場概況

歐洲肌少症治療市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。歐洲在全球肌少症治療市場中佔有重要地位，預計在預測期內複合年成長率顯著。

德國因其創新的醫療保健方法而成為一個有吸引力的市場。根據聯邦統計局統計，2021年該國的醫療支出達4,740億美元。肌少症和 SO 在 70 歲及以上的德國男性中相對罕見（<5%）。因此，骨科疾病病例的激增，加上對營養補充劑的需求不斷成長，推動了德國肌少症治療市場的成長。

歐洲少肌症治療市場收入及 2030 年預測（百萬美元）

歐洲肌少症治療市場區隔

歐洲肌少症治療市場按治療類型、配銷通路和國家分類。

根據治療類型，歐洲肌少症治療市場分為維生素 D 和鈣補充劑、蛋白質補充劑、維生素 B12 補充劑等。 2022 年，維生素 D 和鈣補充劑細分市場佔據歐洲肌肉減少症治療市場佔有率最大的佔有率。

在配銷通路方面，歐洲肌少症治療市場分為藥局、零售通路、線上通路等。 2022 年，藥局領域佔歐洲肌少症治療市場最大佔有率。

依國家/地區分類，歐洲肌少症治療市場分為德國、法國、義大利、英國、西班牙和歐洲其他國家。 2022 年，德國在歐洲肌少症治療市場佔有率中佔據主導地位。

雅培實驗室、安麗公司、拜耳公司、葛蘭素史克公司、Metagenics LLC、雀巢健康科學公司、諾華公司、輝瑞公司和賽諾菲公司是歐洲肌少症治療市場的一些領導公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲少肌症治療市場 - 主要產業動態

  • 歐洲肌少症治療市場 - 主要產業動態
  • 市場促進因素
    • 老年人口激增
    • 成人營養不良和維生素缺乏症增加
  • 主要市場限制：
    • 無法直接干預
  • 主要市場機會：
    • 處於臨床試驗階段的產品
  • 未來趨勢：
    • 人們對肌少症的認知不斷提高
  • 促進因素和限制的影響：

第 5 章：肌少症治療市場 - 歐洲市場分析

  • 歐洲肌少症治療市場收入，2020 - 2030
  • 歐洲肌少症治療市場預測與分析

第 6 章：歐洲肌肉減少症治療市場分析 - 依治療類型

  • 維生素 D 和鈣補充劑
  • 蛋白質補充劑
  • 維生素 B12 補充劑
  • 其他

第 7 章：歐洲肌少症治療市場分析 - 按配銷通路

  • 藥局
  • 零售通路
  • 線上通路
  • 其他

第 8 章：歐洲肌少症治療市場 - 國家分析

  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 9 章：肌少症治療市場-產業格局

  • 概述
  • 肌少症治療市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 10 章：公司簡介

  • Abbott Laboratories
  • Bayer AG
  • Metagenics LLC
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc

第 11 章：附錄

Product Code: BMIRE00030430

The Europe sarcopenia treatment market was valued at US$ 993.46 million in 2022 and is expected to reach US$ 1,467.81 million by 2030; it is estimated to register a CAGR of 5.0% from 2022 to 2030.

Rise in Malnutrition and Vitamin Deficiency Among Adults Boosts Europe Sarcopenia Treatment Market

Malnutrition is one of the major risk factors for sarcopenia. According to the WHO, approximately 2.3 billion adults worldwide were undernourished as of 2021, representing nearly 30% of the global population. Among the reported risk factors, protein-energy deficiency is a frequent cause of sarcopenia. Further, vitamin D deficiency or insufficiency is positively associated with an increased risk of multiple illnesses, such as cancer, obesity, cardiovascular disease, and sarcopenia. According to the National Institutes of Health (NIH), nearly 50% of the world's population suffers from vitamin D insufficiency, and ~1 billion people are vitamin D deficient.

Europe Sarcopenia Treatment Market Overview

The sarcopenia treatment market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global sarcopenia treatment market and is estimated to register a notable CAGR during the forecast period.

Germany is an attractive market due to its innovative approach toward healthcare. According to the Federal Statistical Office, health expenditure in this country amounted to US$ 474 billion in 2021. The awareness of sarcopenia and sarcopenic obesity (SO) is gradually increasing in aging societies across Germany. Sarcopenia and SO are comparatively uncommon (<5%) among German men aged 70 and above. Therefore, an upsurge in the cases of orthopedic disorders, coupled with the rising demand for nutritional supplements, drives the growth of the sarcopenia treatment market in Germany.

Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Sarcopenia Treatment Market Segmentation

The Europe sarcopenia treatment market is categorized into treatment type, distribution channel, and country.

Based on treatment type, the Europe sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Europe sarcopenia treatment market share in 2022.

In terms of distribution channel, the Europe sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Europe sarcopenia treatment market share in 2022.

By country, the Europe sarcopenia treatment market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe sarcopenia treatment market share in 2022.

Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, and Sanofi SA are some of the leading companies operating in the Europe sarcopenia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Sarcopenia Treatment Market - Key Industry Dynamics

  • 4.1 Europe Sarcopenia Treatment Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Upsurge in Geriatric Population
    • 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 4.3 Key Market Restraints:
    • 4.3.1 Unavailability of Direct Interventions
  • 4.4 Key Market Opportunities:
    • 4.4.1 Products in Clinical Trial Phases
  • 4.5 Future Trends:
    • 4.5.1 Rising Awareness About Sarcopenia
  • 4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Europe Market Analysis

  • 5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • 5.2 Europe Sarcopenia Treatment Market Forecast and Analysis

6. Europe Sarcopenia Treatment Market Analysis - By Treatment Type

  • 6.1 Vitamin D and Calcium Supplement
    • 6.1.1 Overview
    • 6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Protein Supplement
    • 6.2.1 Overview
    • 6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Vitamin B12 Supplement
    • 6.3.1 Overview
    • 6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 7.1 Pharmacies
    • 7.1.1 Overview
    • 7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Retail Channels
    • 7.2.1 Overview
    • 7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Online Channels
    • 7.3.1 Overview
    • 7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Sarcopenia Treatment Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Sarcopenia Treatment Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Bayer AG
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Metagenics LLC
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Nestle Health Science SA
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Novartis AG
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Pfizer Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Sanofi SA
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Amway Corp
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 GSK Plc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 7. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 8. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 9. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 10. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 11. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 12. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 13. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 14. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 15. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 16. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 17. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 18. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 21. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Europe Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Europe Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
  • Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 16. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 17. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 18. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 19. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 20. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 21. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 22. Growth Strategies in the Sarcopenia Treatment Market